<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.genengnews.com/gen-news-highlights/oxyrane-raises-26-5m-to-take-lead-enzyme-replacement-therapy-through-phase-i-ii/81245966/>